Inflammatory bowel disease in the elderly: Practical treatment guidelines

Drugs and Aging

Volumn 10, Issue 3, 1997, Pages 199-208

  Akerkar, Geetanjali A ^a   Peppercorn, Mark A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIDIARRHEAL AGENT; ATROPINE PLUS DIPHENOXYLATE; AZATHIOPRINE; BUDESONIDE; CEFALEXIN; CLARITHROMYCIN; CODEINE; COLESTYRAMINE; CORTICOSTEROID; CYCLOSPORIN; HYDROCORTISONE; ICOSAPENTAENOIC ACID; IMMUNOMODULATING AGENT; ISPAGULA; LOPERAMIDE; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; METHYLPREDNISOLONE; METRONIDAZOLE; NICOTINE; OLSALAZINE; PREDNISOLONE; SALAZOSULFAPYRIDINE; SHORT CHAIN FATTY ACID; SPASMOLYTIC AGENT; TETRACYCLINE;

BARIUM MEAL; CLINICAL FEATURE; CLINICAL TRIAL; COLON CARCINOMA; COLON RESECTION; CROHN DISEASE; DIFFERENTIAL DIAGNOSIS; DIVERTICULITIS; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ENTERITIS; GASTROINTESTINAL ENDOSCOPY; HUMAN; HYPERTENSION; INTESTINE INFECTION; INTESTINE ISCHEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; MAINTENANCE THERAPY; META ANALYSIS; NAUSEA; ONSET AGE; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTAL DRUG ADMINISTRATION; REVIEW; SLOW RELEASE FORMULATION; TASTE DISORDER; TRANSDERMAL DRUG ADMINISTRATION; ULCERATIVE COLITIS;

EID: 0030943337     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199710030-00004     Document Type: Review

References (55)

1. Grimm I, Friedman L. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 1990; 1: 361-89
2. Crohn BB, Yarnis H. Regional ileitis. Philadelphia: Grune and Stratton, 1958: 26
3. Regueiro M, Peppercorn MA. Inflammatory bowel disease in the elderly. Resid Staff Physician 1995; 41: 41-6
4. Earle E, Rowe RJ. Ulcerative disease of the large intestine in patients more than 50 years old. Dis Colon Rectum 1972; 15: 33-40
5. Greenstein AJ, Sachar DB, Gibas A, et al. Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol 1985; 7: 137-43
6. Fabricus PJ, Gyde SN, Shouler P, et al. Crohn's disease in the elderly. Gut 1985; 26: 461-5
7. Brandt LJ. Colitis in the elderly. Hosp Pract 1987; 22: 165-88
8. Harper P, McAuliffe T, Beeken W. Crohn's disease in the elderly: a statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986; 146: 753-5
9. Thomas TPL. The complications of systemic corticosteroid treatment in the elderly. Gerontology 1984; 30: 60-5
10. Akerkar GA, Peppercorn MA. Crohn's disease in the elderly. In: Prantera C, Koretlitz BI, editors. Crohn's disease. New York: Marcel Dekker, 1996: 375-83
11. Paul MA, Jorizzo JL, Fleischer Jr AB, et al. Low-dose methotrexate in elderly patients with bullous pemphigoid. J Am Acad Dermatol 1994; 31: 620-5
12. Svartz N. Salazopyrin: a new sulfanilamide preparation. Acta Med Scand 1942; 110: 577-96
13. Sutherland LR, May GR, Shaffer RA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9
14. Dew MJ, Harries AD, Evans N, et al. Maintenance of remission in ulcerative colitis with 5-aminosalicylic acid in high doses by mouth. BMJ 1984; 287: 23-4
15. Singleton J, Gitnick G, Hanauer SB, et al. Response of Crohn's disease to oral Pentasa as a function of disease location and prior therapy: results of a multicenter study. Gastroenterology 1991; 104: 1293-1301
16. Singleton J. Second trial of mesalamine therapy in the treatment of active Crohn's disease [letter]. Gastroenterology 1994; 107: 632-3
17. Messori A, Brignola X, Trallori G, et al. Effectiveness of 5-ASA for maintaining remission in patients with Crohn's disease - a meta-analysis. Am J Gastroenterol 1994; 89 (5): 692-6
18. Thomson ABR, International Mesalazine Study Group. Coated oral 5-ASA vs placebo in maintaining remission of inactive Crohn's disease. Pharmacol Ther 1990; 4: 55-64
19. Caprilli R, Andreoli A, Capursi L, et al. Oral mesalamine for the prevention of post-operative recurrence of Crohn's disease. Aliment Pharmacol Ther 1994; 8: 35-43
20. Peppercorn MA. Advances in drug therapy for inflammatory bowel disease. Ann Intern Med 1990; 112: 50-60
21. Chun A, Korelitz BI. IV ACTH vs hydrocortisone in the treatment of hospitalized patients with Crohn's disease: a randomized double blind study [abstract]. Am J Gastroenlerol 1995; 90: 1657
22. Greenberg G, Feagan B, Martin F, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 835-41
23. Rutgeerts P, Lofberg R, Malchow H, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994; 331: 842-5
24. Novacek G, Kleinberger H, Vogelsang G, et al. Budesonide in chronic active Crohn's disease [abstract]. Gastroenterology 1994; 106: A746
25. Greenberg GR, Feagan B, Martin L, et al. Oral budesonide as maintenance treatment for Crohn's disease: a placebo controlled, dose ranging study. Gastroenterology 1996; 110: 45-51
26. Ursing B, Alm T, Barany F, et al. A comparative study of metronidazole and sulfasalazine for active Crohn's disease. Gastroenterology 1982; 83: 550-62
27. Brandt LJ, Bernstein LH, Boley SJ, et al. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1980; 79: 357-65
28. Rutgeerts P, Hiele M, Peeters K, et al. Prevention of clinical recurrence after ileal resection for Crohn's disease with metronidazole: a placebo controlled study [abstract]. Gastroenterology 1994; 106: A764
29. Gilat T, Suissa A, Leichtman G, et al. A comparative study of metronidazole and sulfasalazine in active not severe UC. J Clin Gastroenterol 1987; 9: 415-7
30. Muss A, Carbone J, Kressel H. Radiologic and clinical assessment of broad spectrum antibiotic therapy in Crohn's disease. Am J Roentgenol 197; 131: 787-90
31. Greenbloom SL, Steinhart AH, Greenberg GR, et al. Ciprofloxacin and metronidazole: combination antibiotic therapy of ileocolonic Crohn's disease [abstract]. Gastroenterology 1995; 108: A827
32. Graham DY, Al-Assi MT, Robinson M. Prolonged remission in Crohn's following therapy for mycobacterium paratuberculosis [abstract]. Gastroenterology 1995; 108: A826
33. Present DH. 6-MP and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis. Gastroenterol Clin North Am 1989; 18: 57-71
34. Wade JF, King TE. Infiltrative and interstitial lung disease in the elderly patient. Clin Chest Med 1993; 14: 501-21
35. Ito T, Yamamoto K, Kinoshita T, et al. The continuous DCMP therapy for acute non-lymphocytic leukemia in elderly patients. Rinsho Ketsueki 1990; 30: 421-8
36. Ruutu T, Almqvist A, Hallman HM, et al. Treatment of acute myeloid leukemia in elderly patients [abstract]. Haematologica 1991; 76: 91
37. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995; 332: 292-7
38. Kozarek RA, Patterson DJ, Gelfand MD. Methotrexate induced clinical and histological remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353-6
39. Lichtiger S, Present D, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994; 330: 1841-5
40. Brynskiv J, Freund L, Rasmussen SN, et al. A placebo-controlled, double blind, randomised trial of cyclosporine therapy in active chronic Crohn's disease. N Engl J Med 1989; 321: 845-50
41. Feagan BG, McDonald JW, Rochon J, et al. Low dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial. N Engl J Med 1994; 330: 1846-51
42. Aslan A, Triadafilopoulos G. Fish oil supplementation in active ulcerative colitis: a double-blind, placebo-controlled, cross-over study. Am J Gastroenterol 1992; 87: 432-7
43. Stenson WF, Cort D, Rodgers J, et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern Med 1992; 116: 609-14
44. Ikehata A, Hiwatashi N, Kinouchi Y, et al. Effect of intravenously infused eicosapentaenoic acid on the leukotriene generation in patients with active Crohn's disease. Am J Clin Nutr 1992; 56: 938-42
45. Breuer RI, Buto SK, Christ MC, et al. Short chain fatty acids for distal ulcerative colitis [abstract]. Gastroenterology 1990; 98: A161
46. Steinhart AH, Hiruki A, Brezezinski JP. Treatment of left-sided ulcerative colitis with butyrate enemas: a randomized controlled trial [abstract]. Gastroenterology 1995; 108: A921
47. Vernia P, Marcheggiano A, Caprilli R, et al. Short chain fatty acid topical treatment in distal ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 309-13
48. Pullan RD, Rhodes J, Ganesh S. Transdermal nicotine treatment for ulcerative colitis. N Engl J Med 1994; 330: 811-5
49. Thomas GA, Rhodes J, Mani V, et al. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995; 332: 988-92
50. Evans RC, Clark L, Heath P, et al. Treatment of ulcerative colitis with an engineered human anti-tnf alpha ab [abstract]. Gastroenterology 1996 Apr; 110: A905
51. McCabe RP, Woody J, Van Deventer S, et al. A multicenter trial of ca2 anti-tnf chimeric monoclonal antibody in patients with Crohn's disease [abstract]. Gastroenterology 1996 Apr; 110: A962
52. Peppercorn M. General principles of medical treatment of ulcerative colitis and Crohn's disease. Semin Gastroenterol 1991; 2: 76-89
53. Zimmennan J, Gavish D, Rachmilewitz D. Early and late onset ulcerative colitis: distinct clinical features. J Clin Gastroenterol 1985; 7: 492-8
54. Harper P, McAuliffe T, Beeken W. Crohn's disease in the elderly: a statistical comparison with younger patients matched for sex and duration of disease. Arch Intern Med 1986; 146: 753-5
55. Goligher JC. Inflammatory disease of the bowel: results of resection for Crohn's disease. Dis Colon Rectum 1976; 19: 584-7